Filing search / Qualigen Therapeutics, Inc. / "Independent"

8-K

EX-3.2

QLGN Qualigen Therapeutics, Inc.

26 Dec 24

Material Modifications to Rights of Security Holders

4:10pm

, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the holders of a majority

8-K/A

EX-10.1

QLGN Qualigen Therapeutics, Inc.

21 Nov 24

Departure of Directors or Certain Officers

5:10pm

. Nature of Relationship The Director is an independent contractor and will not be deemed as an employee of the Company for any purposes by virtue … ; that if he or she is designated by the Board as an independent director, he or she shall promptly notify the Board of any circumstances that may potentially

8-K/A

QLGN Qualigen Therapeutics, Inc.

21 Nov 24

Departure of Directors or Certain Officers

5:10pm

on Form 8-K (the “Initial 8-K Report”) to report the appointment of Graydon Bensler as an independent member of the Board of Directors (the “Board

8-K

EX-3.1

8h02wg

21 Nov 24

Entry into a Material Definitive Agreement

4:10pm

8-K

EX-3.2

chlpyy ekzop

21 Nov 24

Entry into a Material Definitive Agreement

4:10pm

8-K

x5rb4205db qe83066py

13 Nov 24

Departure of Directors or Certain Officers

5:10pm

8-K

EX-10.1

ga5ggly6zn t8xj9usik

13 Nov 24

Departure of Directors or Certain Officers

5:10pm

8-K

vq1h5r1 t0m9269j1mhk

29 Oct 24

Submission of Matters to a Vote of Security Holders

4:05pm

8-K

ihjbuq14k3d

22 Oct 24

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

4:35pm

8-K

o7ym6sr2bg sm

9 Oct 24

Departure of Directors or Certain Officers

4:10pm

8-K

EX-10.1

6uwjw1e0ytwrfp6g1h

9 Oct 24

Departure of Directors or Certain Officers

4:10pm